Why is eczema herpeticum unexpectedly rare?

Area of Science:

• Immunology
• Dermatology
• Virology

Background:

• Atopic dermatitis (AD) is a common chronic inflammatory skin disease.
• AD patients have increased susceptibility to cutaneous infections, including herpes simplex virus (HSV).
• Severe HSV infection, known as eczema herpeticum (EH), is rare in AD patients.

Purpose of the Study:

• To investigate host factors contributing to the rare occurrence of eczema herpeticum in atopic dermatitis patients (ADEH+).
• To compare clinical and immunological characteristics of ADEH+ patients versus those without EH (ADEH-).

Main Methods:

• Comparative analysis of ADEH+ and ADEH- patient cohorts.
• Assessment of AD severity, immune biomarkers (Th2 responses, interferon levels, IgE), epidermal barrier proteins (filaggrin), and antimicrobial peptides.
• Evaluation of patient history for allergies, asthma, AD onset, and other cutaneous infections.

Main Results:

• Patients prone to EH (ADEH+) exhibit more severe AD.
• ADEH+ patients show biomarkers of Th2-skewed immune responses, including reduced interferon, elevated eosinophils, increased IgE, and allergen sensitization.
• Decreased epidermal filaggrin and antimicrobial peptide expression are observed in ADEH+ subjects.
• ADEH+ individuals are more likely to have a history of food allergy, asthma, early-onset AD, and prior infections with Staphylococcus aureus or molluscum contagiosum.

Conclusions:

• Multiple host factors, including AD severity, specific immune profiles, and epidermal barrier defects, contribute to the rare development of EH in AD patients.
• Understanding these factors may inform strategies for preventing severe HSV infections in this vulnerable population.